Medscape Medical NewsAll articles

EchoGo Core

Ultromics Ltd • Radiology • 11/13/2019

510(k)IEC 62304 Class B
FDA Summary PDF

Device Purpose

EchoGo Core is a software application that utilizes machine learning algorithms to automatically analyze echocardiograms and quantify key cardiac parameters such as Ejection Fraction, Global Longitudinal Strain, and Left Ventricular volume. Its methodology aims to support physician diagnosis by providing standardized, reproducible measurements of cardiovascular function in adult patients, notably reducing operator-dependent variability in contouring.

Summary

EchoGo Core is a standalone software application designed for the automated quantification and reporting of cardiovascular function in adult populations, serving as an aid to physician diagnosis. The system processes anonymized echocardiogram datasets using a machine learning-based algorithm for auto-contouring of the left ventricular (LV) endocardium. These automatically generated contours, following review and approval by trained operators, are utilized to calculate critical cardiac parameters including Ejection Fraction (EF) via Simpson’s Biplane Method (SBM), Global Longitudinal Strain (GLS) averaged from two and four-chamber views, and LV volumes also using SBM, with results compiled into a clinician's report. Performance evaluations demonstrated EchoGo Core's capabilities, particularly in comparison to predicate devices like TomTec Arena TTA2, highlighting improvements in consistency. A significant distinction is EchoGo Core's use of machine learning and its preclusion of manual contour editing, a feature available in the predicate. This design choice, supported by an input image quality control procedure, successfully eliminated inter- and intra-operator variability (0% bias and RMSE). In contrast, the predicate required manual editing in up to 100% of cases, while EchoGo Core necessitated complete contour rejection in up to 29% of instances. A retrospective validation study involving 378 patient studies confirmed that EchoGo Core met its primary endpoints, achieving Root Mean Square Error (RMSE) values of 5.02% for EF, 2.89% for GLS, 8.0 ml for end-diastolic volume, and 11.1 ml for end-systolic volume compared to predicate-derived reference values.

AI Regulatory Concerns

Powered byJev by TypeSafe AI

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

Keywords

EchocardiogramLeft Ventricle (LV)Ejection Fraction (EF)Global Longitudinal Strain (GLS)Auto-contouringMachine LearningCardiovascular FunctionSimpson’s Biplane MethodImage Analysis SoftwareOperator Variability

Device Metadata

Submission Number
K191171
Company
Ultromics Ltd
Panel
Radiology
Product Code
N/A
Data Type
Images
Clinical Function
Assessment
AI Function
Analysis
AI Subclass
quantification/feature localization

Relevant Clinical Questions

  • Q1. How does the machine learning algorithm in EchoGo Core adapt to variations in image quality across different ultrasound scanner platforms, and what is the impact on contour accuracy and the 29% rejection rate?; What specific features or image characteristics trigger a 'poor contour tracking' rejection by EchoGo Core, and are there plans to refine the algorithm to reduce this rejection rate?; Given that EchoGo Core eliminates manual editing and inter/intra-operator variability, how does its diagnostic accuracy for specific cardiac conditions compare to systems allowing manual adjustments by expert clinicians?; What were the 'set thresholds' for Root Mean Square Error (RMSE) in the performance testing, and how do the achieved RMSE values (e.g., 5.02% for EF) clinically correlate with diagnostic confidence and patient outcomes?; How does the review and approval process by 'trained operators' for the automated contours ensure that the machine learning output is clinically sound, especially in complex or atypical cardiac anatomies?

Risk Classification

ESL Analysis
FDA Device ClassII

FDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Authorized before §524B enforcement

Learn how Parasoft automates IEC 62304 compliance testing →

Cybersecurity Evidence

Powered by SBOMator™

Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.

Cyber Score30/100
SBOM Evidence⚠ Not mentioned in summary
Cyber Risk Assessment✓ Detected in Summary
Postmarket Plan⚠ Not mentioned in summary
§524B ApplicableNo

Supply Chain BOM Evidence

Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.

SBOMSoftware Bill of Materials
- Not detected
ML-BOMMachine Learning Bill of Materials(machine learning, algorithm, dataset, bias)
✓ Detected
SaaSBOMSoftware-as-a-Service Bill of Materials(platform)
✓ Detected
HBOMHardware Bill of Materials
- Not detected
CBOMCryptography Bill of Materials
- Not detected
VDR/VEXVulnerability Disclosure Report / Vulnerability Exploitability eXchange
- Not detected
OBOMOperations Bill of Materials
- Not detected

Analysis:

• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.

• Evidence of ML-BOM, SaaSBOM detected in AI-generated device summary.

• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.

• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.

• Not detected in AI-generated device summary: SBOM, HBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.

Preparing a similar submission?

ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.

Assess Your Readiness →Or contact ESL directly
EchoGo Core - Ultromics Ltd | ESL FDA AI Device Intelligence